Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations

M Parotto, M Gyöngyösi, K Howe, SN Myatra… - The Lancet …, 2023 - thelancet.com
Individuals with SARS-CoV-2 infection can develop symptoms that persist well beyond the
acute phase of COVID-19 or emerge after the acute phase, lasting for weeks or months after …

Long COVID: a clinical update

T Greenhalgh, M Sivan, A Perlowski, JŽ Nikolich - The Lancet, 2024 - thelancet.com
Summary Post-COVID-19 condition (also known as long COVID) is generally defined as
symptoms persisting for 3 months or more after acute COVID-19. Long COVID can affect …

Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors

X Gu, S Wang, W Zhang, C Li, L Guo, Z Wang, H Li… - …, 2023 - thelancet.com
Background As a debilitating condition that can impact a whole spectrum of people and
involve multi-organ systems, long COVID has aroused the most attention than ever …

Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness

P Pandharipande, SW Roberson… - The Lancet …, 2023 - thelancet.com
Despite advances in the treatment and mitigation of critical illness caused by infection with
SARS-CoV-2, millions of survivors have a devastating, post-acute infection syndrome known …

Using cardiorespiratory fitness assessment to identify pathophysiology in long COVID–Best practice approaches

MA Faghy, C Dalton, R Duncan, R Arena… - Progress in …, 2024 - Elsevier
Cardio-respiratory fitness (CRF) is well-established in the clinical domains as an integrative
measure of the body's physiological capability and capacity to transport and utilise oxygen …

MicroRNA‐guided drug discovery for mitigating persistent pulmonary complications in critical COVID‐19 survivors: A longitudinal pilot study

MC García‐Hidalgo, ID Benítez… - British Journal of …, 2025 - Wiley Online Library
Abstract Background and Purpose The post‐acute sequelae of SARS‐CoV‐2 infection pose
a significant global challenge, with nearly 50% of critical COVID‐19 survivors manifesting …

Pulmonary sequelae of COVID-19: focus on interstitial lung disease

J Johnston, D Dorrian, D Linden, SC Stanel… - Cells, 2023 - mdpi.com
As the world transitions from the acute phase of the COVID-19 pandemic, a novel concern
has arisen—interstitial lung disease (ILD) as a consequence of SARS-CoV-2 infection. This …

The biomarkers' landscape of post-COVID-19 patients can suggest selective clinical interventions

D Paris, L Palomba, MC Albertini, A Tramice, L Motta… - Scientific Reports, 2023 - nature.com
In COVID-19 clinical symptoms can persist even after negativization also in individuals who
have had mild or moderate disease. We here investigated the biomarkers that define the …

Long COVID—unravelling a complex condition

CL Hodgson, T Broadley - The Lancet Respiratory Medicine, 2023 - thelancet.com
Long COVID is an overarching term that was originally coined by patients and is widely used
to describe ongoing symptoms after the acute phase of COVID-19, including both short-term …

[HTML][HTML] Characterization of dipyridamole as a novel ferroptosis inhibitor and its therapeutic potential in acute respiratory distress syndrome management

X Chen, J Shen, X Jiang, M Pan, S Chang, J Li… - …, 2024 - pmc.ncbi.nlm.nih.gov
Rationale: Ferroptosis in lung epithelium and endothelium contributes to the pathogenesis
of acute respiratory distress syndrome (ARDS), a critical and often fatal condition marked by …